Physicians' Academy for Cardiovascular Education

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy
Download your free copy

This document covers five topics that help cardiologists understand what is important when treating patients with diabetes, and which risks these patients face. Download your free copy.

Hypoglycemia in cardiovascular medicine: why worry?

5 Things a cardiologist needs to know about diabetes

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Rudolfstiftung Hospital, Vienna, Austria
Several factors make a diabetes patient more vulnerable to severe hypoglycemia events, which are associated with higher CV morbidity and mortality. Prof Schernthaner discusses how hypoglycemia can be prevented.

5 Things a cardiologist needs to know about diabetes Several factors make a diabetes patient more vulnerable to severe hypoglycemia events, which are associated with higher CV morbidity and mortality. Prof Schernthaner discusses how hypoglycemia can be prevented.

Key classes of antidiabetic drugs – How do they work?

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof Cliff Bailey - Birmingham, UK
Multiple causal pathways contribute to development of T2DM, thus various processes may be targeted to improve glucose regulation. Prof. Bailey briefly summarises the available therapeutic options.

5 Things a cardiologist needs to know about diabetes Multiple causal pathways contribute to development of T2DM, thus various processes may be targeted to improve glucose regulation. Prof. Bailey briefly summarises the available therapeutic options.

Diabetes cardiovascular outcome trials

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof. Lawrence Leiter, MD - Toronto, ON, Canada
Prof Leiter gives an update of the trials on new antihyperglycemic drugs that have been completed or are ongoing since the FDA mandated demonstration of CV safety. Trials evaluating DPP-4 inhibitors, GLP-1 receptor agonists and SGLT2 inhibitors on CV outcomes are being discussed.

5 Things a cardiologist needs to know about diabetes Prof Leiter gives an update of the trials on new antihyperglycemic drugs (DPP-4 inhibitors, GLP-1 receptor agonists and SGLT2 inhibitors) that have been completed or are ongoing since the FDA mandated demonstration of CV safety.

HbA1c in CVD

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof Naveed Sattar, MD - University of Glasgow, United Kingdom
Prof Naveed Sattar discusses the value of HbA1c to diagnose T2DM, and how HbA1c levels are related to the risk of developing micro and macrovascular disease and the consequences thereof for choosing a HbA1c therapeutic target.

5 Things a cardiologist needs to know about diabetes Prof Naveed Sattar discusses the value of HbA1c to diagnose T2DM, and how HbA1c levels are related to the risk of developing micro and macrovascular disease and the consequences thereof for choosing a HbA1c therapeutic target.

Natural history of DM: Focus on micro- and macrovascular complications

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 13, 2018 - Prof. Kausik Ray, Imperial College Londen, UK
Prof. Ray focuses on micro- and macrovascular disease in type 2 diabetes, their implications, their interrelationship and how these risks can be modified by new glucose-lowering agents.

5 Things a cardiologist needs to know about diabetes Prof. Ray focuses on micro- and macrovascular disease in type 2 diabetes, their implications, their interrelationship and how these risks can be modified by new glucose-lowering agents.

5 Things a cardiologist should know about diabetes
5 Things a cardiologist should know about diabetes